Research criteria for subcortical vascular dementia in clinical trials
Vascular dementia (VaD) incorporate different vascular mechanisms and changes in the brain, and have different causes and clinical manifestations. Variation in defining the cognitive syndrome, in vascular etiologies, and allowable brain changes in current clinical definitions of VaD have resulted in variable estimates of prevalence, of groups of subjects, and of the types and distribution of putative causal brain lesions. Thus current criteria for VaD select an etiologically and clinically heterogeneous group. This definitional heterogeneity may have been a factor in “negative” clinical trials. An alternative for clinical drug trials is to focus on a more homogenous group, such as those with subcortical (ischemic) VaD. This designation incorporates two small vessel clinical entities “Binswanger’s disease” and “the lacunar state”. It comprises small vessel disease as the primary vascular etiology, lacunar infarct(s) and ischaemic white matter lesions as the primary type of brain lesions, and subcortical location as the primary location of lesions. The subcortical clinical syndrome is the primary clinical manifestation, a definition which still requires additional empirical data. We expect that subcortical VaD show a more predictable clinical picture, natural history, outcome, and treatment responses. We propose a modification of the NINDS-AIREN criteria as a new research criteria for subcortical VaD.
KeywordsVascular Dementia White Matter Lesion Small Vessel Disease Lacunar Infarct Deep White Matter Lesion
Unable to display preview. Download preview PDF.
- Chui HC (1998) Rethinking vascular dementia: moving from myth to mechanism. In: Growdon JH, Rossor MN (eds), The dementias. Butterworth-Heinemann, Boston, pp 377 – 401Google Scholar
- Desmond DW (1996) Vascular dementia: a construct in evolution. Review. Cerebrovasc Brain Metabol Rev 8: 296 – 325Google Scholar
- Erkinjuntti T (1996) Clinicopathological study of vascular dementia. In: Prohovnik I, Wade J, Knezevic S, Tatemichi TK, Erkinjuntii T (eds), Vascular dementia. Current concepts. John Wiley, Chichester, pp 73 – 112Google Scholar
- Molnar F, Hing M, St John P, Brymer C, Rockwood K, Hachinski V (1999) National survey on the treatment of and future research into subcortical vascular dementia. Can J Neur Sci 25: 320 – 324Google Scholar
- Rockwood K, Bowler J, Erkinjunti T, Hachinski V, Wallin A (1999a) Subtypes of vascular dementia. Alzheimer Dis Assoc Disord 13[Suppl 3]: S59-S65 Rockwood K, Howard K, MacKnight C, Darvesh S (1999b) Spectrum of disease in vascular cognitive impairment. Neuroepidemiology 18: 248 – 254CrossRefGoogle Scholar
- Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennet DP, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartman A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250 – 260PubMedGoogle Scholar